Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions he has had with NHS England on ensuring that GP practices follow the NICE guideline entitled Attention deficit hyperactivity disorder: diagnosis and management, last updated on 13 September 2019, on Shared Care Agreements in cases where a patient has received a diagnosis from a qualified provider.

The Secretary of State for Health and Social Care has regular discussions on a wide range of matters with NHS England.

It is the responsibility of integrated care boards (ICBs) in England to make available appropriate provision to meet the health and care needs of their local population, including providing access to attention deficit hyperactivity disorder (ADHD) assessment and treatment, in line with relevant National Institute for Health and Care Excellence (NICE) guidelines.

It is for the responsible clinician to decide on the most appropriate treatment plan to manage ADHD in discussion with their patient. This decision is based on the clinician’s expertise regarding treatment options, evidence, risk and benefits and the patient’s personal circumstances as part of a shared decision-making process. The NICE guidelines on ADHD set out the considerations that healthcare professionals should take into account when considering treatment options.

Shared care within the NHS refers to an arrangement whereby a specialist doctor formally transfers responsibility for all or some aspects of their patient’s care, such as prescription of medication, over to the patient’s general practitioner (GP). The General Medical Council (GMC) has issued guidance on prescribing and managing medicines, which helps GPs decide whether to accept shared care responsibilities. The GMC has made it clear that GPs cannot be compelled to enter into a shared care agreement. GP practices may decline such requests on clinical or capacity grounds. If a shared care arrangement cannot be put in place after the treatment has been initiated, the responsibility for continued prescribing falls upon the specialist clinician. This applies to both NHS and private medical care.